In this retrospective study, we investigated the prognostic role of galectin-3 and ERα, in predicting aggressiveness, post-surgical outcome, and responsiveness to DA therapy, in patients who underwent first line surgery for PRL-secreting pituitary tumors. Here, PRL is linked to pituitary tumor.